Pediatric issues in underwriting

Steven L Cooper1

  • 1Lincoln National Life, 350 Church Street, Hartford, CT 06103, USA. slcooper@lnc.com

Insights

Assessing mortality risk for children with health impairments is complex. Key factors include the severity of neonatal lung disease, ventilator support duration, and the presence of developmental disorders, influencing accident and long-term health risks.

Area of Science:

  • Pediatric mortality risk assessment
  • Life insurance underwriting
  • Neonatal care outcomes

Background:

  • Advances in neonatal care increase survival rates for premature infants with chronic respiratory and neurological conditions.
  • Assessing mortality risk for juvenile life insurance applicants with impairments presents unique challenges.
  • Understanding long-term health trajectories for children with neonatal conditions is crucial for accurate risk stratification.

Purpose of the Study:

  • To identify key factors influencing mortality risk in juvenile life insurance applicants with pre-existing health impairments.
  • To provide a framework for evaluating the long-term mortality patterns of impaired pediatric lives.
  • To inform underwriting practices for life insurance policies involving children with complex medical histories.

Main Methods:

  • Analysis of mortality patterns in impaired pediatric populations.
  • Identification of specific medical conditions (e.g., neonatal lung disease, autism, ADHD) and their impact on risk.
  • Evaluation of factors such as ventilator support duration and co-occurring disorders.

Main Results:

  • Neonatal lung disease severity and duration of ventilator support are significant predictors of mortality risk.
  • Autism spectrum disorder, without other neurological conditions, primarily presents an accident risk.
  • Attention deficit hyperactivity disorder (ADHD) without conduct disorder is associated with a lower risk of substance abuse.

Conclusions:

  • Mortality risk in impaired pediatric life insurance applicants is highly dependent on the specific condition and its management.
  • Accidental death is a predominant mortality factor in certain pediatric impairment groups.
  • Accurate risk assessment requires a nuanced understanding of diverse developmental and respiratory disorders in childhood.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).